Industry | 2022.03.29
Owen Mumford And Noble International Announce Collaboration On Patient Training Solutions For UniSafe® Drug Delivery Devices
Owen Mumford Pharmaceutical Services, a division of Owen Mumford Ltd, which specialises in the design, development and manufacture of injectable drug delivery systems for the pharmaceutical, biotech and generics industries, announces its alliance with Noble International, an Aptar Pharma company and world leader in providing drug delivery training device programs for pharmaceutical companies and original equipment manufacturers. Through this agreement, Noble will develop patient-focused training devices for Owen Mumford’s safety syringe platform UniSafe®. Noble will also develop and provide comprehensive training programs and materials to support and educate patients on their injection devices with the aim of improving therapy adherence and patient confidence.
(PRWeb March 29, 2022)
Read the full story at https://www.prweb.com/releases/2022/3/prweb18570598.htm
For more information, please visit
https://www.prweb.com/releases/2022/3/prweb18570598.htm
